Artificial Intelligence in Healthcare: Managing the Growing Risk to Patient Confidentiality
Artificial intelligence is rapidly transforming the healthcare industry. Hospitals, physician groups, insurers, and healthcare technology vendors are increasingly integrating AI tools into clinical workflows and administrative processes. With good reason, AI offers powerful opportunities to improve efficiency and patient outcomes, including everything from diagnostic support and predictive analytics to automated documentation and virtual assistants.
However, the use of AI in healthcare raises significant legal risks, particularly concerning patient confidentiality. As healthcare organizations adopt these tools, protecting sensitive health information must remain a central consideration.
How AI is Being Used Across Healthcare Operations
AI technologies are now embedded in many aspects of healthcare delivery. Common applications include:
- AI-assisted medical imaging and diagnostics
- Clinical decision support tools
- Predictive analytics for patient outcomes and readmission risk
- Automated medical coding and billing systems
- AI-powered transcription and documentation tools
- Patient-facing chatbots and virtual assistants
While these tools can increase efficiency and support better clinical decision-making, they often require access to large volumes of patient data to function effectively, which frequently includes protected health information (PHI).
Where Confidentiality Risks Arise
AI-related confidentiality risks can emerge in several ways:
Unintended Data Disclosure
Some AI platforms store user inputs to improve their underlying models. If a healthcare provider enters identifiable patient information into such a system, that data may be retained outside the organization’s secure environment, potentially leading to unauthorized access.
Third-Party Vendor Exposure
Many AI solutions are offered through third-party vendors. When these vendors have access to PHI, they may qualify as “business associates” under HIPAA, requiring formal Business Associate Agreements (BAAs) and adherence to strict privacy standards.
Data Aggregation and Re-Identification
AI systems often rely on large datasets that combine information from multiple sources. Even when patient information has been de-identified, sophisticated data analysis techniques could lead to re-identification of individuals.
Internal Use Without Governance
Another emerging risk involves internal experimentation with AI tools. Healthcare professionals may begin using generative AI systems without proper oversight, increasing the potential for unintentional data breaches.
Regulatory Scrutiny Is Increasing
Regulators are paying close attention to the intersection of AI and healthcare privacy. The U.S. Department of Health and Human Services (HHS) is examining how existing HIPAA rules apply to emerging AI technologies. Concurrently, the Federal Trade Commission (FTC) has indicated it will pursue enforcement actions against companies that mishandle health-related data.
Additionally, many states are expanding consumer data privacy laws to include health-related information, imposing further obligations on healthcare entities using AI tools.
Practical Steps for Healthcare Organizations
Healthcare organizations can take several steps to reduce confidentiality risks while benefiting from AI innovation:
Establish Clear AI Governance Policies
Organizations should develop internal policies governing when and how AI tools may be used. These policies should address the types of information that may be entered into AI platforms and outline necessary approval processes.
Conduct Vendor Due Diligence
Before implementing AI solutions, organizations should thoroughly evaluate vendors’ data security practices. Critical questions include:
- How is patient data stored and encrypted?
- Will the vendor retain or use the data to train its AI models?
- Does the vendor require access to PHI?
- Is the vendor willing to execute a HIPAA-compliant Business Associate Agreement?
Limit Data Exposure
Whenever possible, organizations should minimize the amount of PHI shared with AI systems. Data can often be de-identified or anonymized before being used for AI-driven analysis.
Train Employees on Responsible AI Use
Education is crucial for risk management. Healthcare professionals should understand that entering patient information into consumer-grade AI tools may violate privacy obligations.
Preparing for Responsible AI Adoption
Artificial intelligence will undoubtedly play an increasingly significant role in the future of healthcare. The technology offers enormous potential to enhance diagnostics, improve operational efficiency, streamline clinical workflows, and support better patient care.
However, the rapid pace of innovation should not outstrip careful consideration of patient privacy. Healthcare organizations that approach AI adoption with thoughtful governance and clear privacy safeguards will be better positioned to harness the benefits of AI while maintaining the confidentiality of patient information.
